N-Acetyl-4-Thiazolidine Carboxylic Acid

We are N-Acetyl-4-Thiazolidine Carboxylic Acid CAS:5025-82-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

N-Acetyl-4-Thiazolidine Carboxylic Acid
 
CAS Number: 5025-82-1
Molecular Formula: C6H9NO3S
Molecular Weight: 175.21
EC Number: 225-713-6
 
Synonyms: 
folcisteine;
acetyl-thiazolidine-4-carboxylic acid;
n-acetyl-thiazolidine-4-carboxylic acid;
NATCA
 
Specification:
ITEMS SPECIFICATIONS
   
Appearance White crystals or crystalline powder
Identification (IR) Positive
Specific Rotation -130° to -145°
State of Solution 95.0% Min.
Chloride (Cl) 0.05% Max.
pH 2.0 – 2.8
Ammonium (NH4) 0.02% Max.
Sulfate (SO4) 0.03% Max.
Iron (Fe) 10 ppm Max.
Heavy Metals (Pb) 10 ppm Max.
Arsenic (As2O3) 1 ppm Max.
Other Amino Acids Chromatographically
Not Detected
Assay 98.5 – 101.0%

Application: N-Acetyl-4-Thiazolidine Carboxylic Acid is an active ingredient derived from the Sulphur-rich Amino-Acid-L-Cysteine. It is used as a biological stimulant and plant growth enhancer.
N-Acetyl-4-Thiazolidine Carboxylic Acid


Related News: The glucagon-only configuration may be helpful in rare conditions that often lead to chronic, low blood-sugar conditions, such as congenital hyperinsulinism (CHI).ácido ciclobutano-1,1-dicarboxílico CAS:5445-51-2 The glucagon-only configuration may be helpful in rare conditions that often lead to chronic, low blood-sugar conditions, such as congenital hyperinsulinism (CHI).Bis(2,6-difluoro-3-(1-hydropyrrol-1-yl)phenyl)titanocene The Company’s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs).4-Boc-aminopiperidine The Company’s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs).In addition, although the API and intermediate industries are capital-intensive and technology-intensive industries, new competitors are still joining.

Related Products
Product Name
5,6-Dimethoxy-2-(4-Piperidinylmethyl)-1-Indanone Hydrochloride View Details
Hexadecanethiol View Details
Amino Trimethylene Phosphonic Acid View Details
(3R,4S)-1-Benzoyl-3-(1-ethoxyethoxy)-4-phenyl-2-azetidinone manufacturer dimethyl 2-fluoropropanedioate Cas:344-14-9 manufacturer Nesiritide acetate manufacturer 2,3,4,5-Tetrahydro-1H-pyrido[4,3-b]indole hydrochloride manufacturer Myristoyl Hexapeptide-23 manufacturer